1. Home
  2. WHWK vs SOL Comparison

WHWK vs SOL Comparison

Compare WHWK & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHWK
  • SOL
  • Stock Information
  • Founded
  • WHWK 2007
  • SOL 2005
  • Country
  • WHWK United States
  • SOL United States
  • Employees
  • WHWK N/A
  • SOL N/A
  • Industry
  • WHWK Biotechnology: Pharmaceutical Preparations
  • SOL Semiconductors
  • Sector
  • WHWK Health Care
  • SOL Technology
  • Exchange
  • WHWK Nasdaq
  • SOL Nasdaq
  • Market Cap
  • WHWK 95.2M
  • SOL 98.5M
  • IPO Year
  • WHWK N/A
  • SOL 2008
  • Fundamental
  • Price
  • WHWK $2.31
  • SOL $1.86
  • Analyst Decision
  • WHWK
  • SOL Strong Buy
  • Analyst Count
  • WHWK 0
  • SOL 2
  • Target Price
  • WHWK N/A
  • SOL $4.50
  • AVG Volume (30 Days)
  • WHWK 5.1M
  • SOL 208.5K
  • Earning Date
  • WHWK 11-15-2025
  • SOL 11-13-2025
  • Dividend Yield
  • WHWK N/A
  • SOL N/A
  • EPS Growth
  • WHWK N/A
  • SOL N/A
  • EPS
  • WHWK N/A
  • SOL N/A
  • Revenue
  • WHWK $21,596,000.00
  • SOL $68,445,000.00
  • Revenue This Year
  • WHWK N/A
  • SOL N/A
  • Revenue Next Year
  • WHWK N/A
  • SOL $45.37
  • P/E Ratio
  • WHWK N/A
  • SOL N/A
  • Revenue Growth
  • WHWK N/A
  • SOL N/A
  • 52 Week Low
  • WHWK $1.39
  • SOL $1.04
  • 52 Week High
  • WHWK $3.81
  • SOL $2.68
  • Technical
  • Relative Strength Index (RSI)
  • WHWK 56.25
  • SOL 49.63
  • Support Level
  • WHWK $1.87
  • SOL $1.81
  • Resistance Level
  • WHWK $2.72
  • SOL $1.87
  • Average True Range (ATR)
  • WHWK 0.31
  • SOL 0.03
  • MACD
  • WHWK 0.04
  • SOL -0.00
  • Stochastic Oscillator
  • WHWK 25.26
  • SOL 46.59

About WHWK Whitehawk Therapeutics Inc. Common Stock

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

About SOL Emeren Group Ltd each representing 10 shares

Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.

Share on Social Networks: